Is MAGED2 p.Thr132= (c.396A>G) pathogenic?

MAGED2 p.Thr132= (c.396A>G) is classified Benign in MAGED2 (ClinVar, Multiple submitters, 6 submitters; last evaluated 2026-02-04). Common (popmax 67.4%, afr) — too common for a highly-penetrant pathogenic allele; Associated with Bartter disease type 5.

What condition is associated with MAGED2 p.Thr132= (c.396A>G)?

MAGED2 p.Thr132= (c.396A>G) is associated with Bartter disease type 5 (ClinVar).

How is Bartter syndrome inherited?

Typically Autosomal dominant, Autosomal recessive (Orphanet). A genetic counselor can assess individual risk for a family.

MAGED2 p.Thr132=

Q: How common is MAGED2 p.Thr132= (c.396A>G) in the general population?

MAGED2 p.Thr132= (c.396A>G) is common (popmax 67.4%, afr) — too common for a highly-penetrant pathogenic allele (gnomAD).

c.396A>G · rs1043034 · VCV1258035

Benign Multiple submitters

Classification

Benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 6 submitters

gnomAD v4.1

Common

common (popmax 67.4%, afr) — too common for a highly-penetrant pathogenic allele

Conditions

Bartter disease type 5

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -5.3	GERP -3.9
Overall
CADD	2.453	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 67.4% African / African-American · 37,751/56,048 alleles

Filtering AF 66.8% ClinGen BA1/BS1 input FAF95, joint · FAF99 66.6%

Overall 37.3% 448,704/1,203,510 alleles · common exomes 400,152/1,094,553 · genomes 48,552/108,957 · joint denominator

Ancestry group	Frequency	1 in
African / African-Americangrpmax	67.4%	1
East Asian	63.5%	2
Finnishnot grpmax-eligible	40.3%	2
South Asian	38.9%	3
Ashkenazi Jewishnot grpmax-eligible	37.8%	3
Remaining individualsnot grpmax-eligible	37.8%	3
Admixed American	36.5%	3
European (non-Finnish)	34.2%	3
Middle Eastern	31.9%	3
Amishnot grpmax-eligible	11.2%	9

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MAGED2
Protein: p.Thr132=
Coding: c.396A>G
MANE Select: NM_177433
dbSNP: rs1043034
Type: single nucleotide variant
Location: chrX:54810072 (GRCh38)
Structure: AlphaFold pLDDT 59.89
Residue 132: the 'disordered' region

Full MAGED2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Bartter disease type 5 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Bartter syndrome (Orphanet):

Inheritance: Autosomal dominant, Autosomal recessive, X-linked recessive
Onset: Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
Prevalence: 1-9 / 1 000 000 (Europe)

Similar variants

MAGED2 p.Thr132Ile Uncertain significance ⚠ same residue
MAGED2 p.Pro153Ser Uncertain significance ★★ ⚠ same condition
MAGED2 p.Ala208= Benign ★★ same condition
MAGED2 p.Pro272= Benign/Likely benign ★★ same condition
MAGED2 p.Ser327= Benign ★★ same condition
MAGED2 p.Ser84= Benign ★★ same condition
MAGED2 c.1386+1G>A Likely pathogenic ★ same condition
MAGED2 p.Arg446Cys Likely pathogenic ★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/maged2-p-thr132 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown